The development of pharmaceutical analytical methods represents one of the most
significant aspects of drug development. Recent advances in microfabrication and …

Droplet-based bioprinting (DBB) offers greater advantages due to its simplicity and agility
with precise control on deposition of biologics including cells, growth factors, genes, drugs …

Significant advances in biomaterials, stem cell biology, and microscale technologies have
enabled the fabrication of biologically relevant tissues and organs. Such tissues and organs …

Successful launch of a commercial drug requires significant investment of time and financial
resources wherein late-stage failures become a reason for catastrophic failures in drug …

In the tissue engineering (TE) paradigm, engineering and life sciences tools are combined
to develop bioartificial substitutes for organs and tissues, which can in turn be applied in …

Highlights•Bioprinting is a powerful technology in tissue and organ fabrication.•Bioprinting
has gained significant interest in medicine and pharmaceutics.•Bioprinting has been widely …

The natural microenvironment of tumors is composed of extracellular matrix (ECM), blood
vasculature, and supporting stromal cells. The physical characteristics of ECM as well as the …

Reconstruction of bony defects is challenging when conventional grafting methods are used
because of their intrinsic limitations (biological cost and/or biological properties). Bone …

Bioprinting is an emerging research field that has attracted tremendous attention for various
applications; it offers a highly automated, advanced manufacturing platform for the …

Microfluidics is an emerging and promising interdisciplinary technology which offers
powerful platforms for precise production of novel functional materials (eg, emulsion …